Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81

Affiliations

¹ GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: thomas.seisen@aphp.fr.
² GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France.
³ Oncostat U1018 Inserm, Department of Radiation Oncology, Gustave-Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.

Comment

Thomas Seisen et al. Eur Urol. 2024 Jan.

. 2024 Jan;85(1):e24.

doi: 10.1016/j.eururo.2023.07.019. Epub 2023 Aug 31.

¹ GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: thomas.seisen@aphp.fr.
² GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France.
³ Oncostat U1018 Inserm, Department of Radiation Oncology, Gustave-Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.

No abstract available

Comment on

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202